Baillie Gifford & Co
AFIB

Baillie Gifford & Co’s Acutus Medical Inc AFIB Stock Holding History

Baillie Gifford & Co’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-424
Closed -$320 – 447
2023
Q1 		$320 Hold
424
– – ﹤0.01% 451
2022
Q4 		$488 Hold
424
– – ﹤0.01% 485
2022
Q3 		$0 Hold
424
– – ﹤0.01% 500
2022
Q2 		$0 Hold
424
– – ﹤0.01% 515
2022
Q1 		$1K Hold
424
– – ﹤0.01% 495
2021
Q4 		$1K Hold
424
– – ﹤0.01% 498
2021
Q3 		$4K Hold
424
– – ﹤0.01% 485
2021
Q2 		$7K Hold
424
– – ﹤0.01% 456
2021
Q1 		$6K Buy
424
+6
+1% +$135 ﹤0.01% 431
2020
Q4 		$12K Buy
+418
New +$11.3K ﹤0.01% 374

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return